BCR-ABL interphase fish provides higher sensitivity and new biological insights into Ph-positive leukemias.

被引：0
|
作者：
Najfeld, V [1 ]
Burnett, W [1 ]
Boczkowska, B [1 ]
机构：
[1] MT SINAI MED CTR,DEPT MED,NEW YORK,NY 10029
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1471 / 1471
页数：1
相关论文
共 38 条
  • [21] Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain in Philadelphia-positive leukemias.
    Soverini, Simona
    De Benedittis, Caterina
    Polakova, Katerina Machova
    Brouckova, Adela
    Castagnetti, Fausto
    Papayannidis, Cristina
    Gugliotta, Gabriele
    Palandri, Francesca
    Klamova, Hana
    Iacobucci, Ilaria
    Venturi, Claudia
    Cattina, Frederica
    Bresciani, Paola
    Coluccio, Valeria
    Salvucci, Marzia
    Tiribelli, Mario
    Binotto, Gianni
    Intermesoli, Tamara
    Luppi, Mario
    Bochicchio, Maria Teresa
    Ottaviani, Emanuela
    Russo, Domenico
    Gianantonio, Rosti
    Baccarani, Michele
    Martinelli, Giovanni
    CANCER RESEARCH, 2013, 73 (08)
  • [22] DETECTION OF MBCR-ABL REARRANGEMENT BY INTERPHASE-FLUORESCENT IN-SITU HYBRIDIZATION (I-FISH) IN PH-POSITIVE LEUKEMIA
    HERDEN, MJ
    DEBAUCHE, DM
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 1521 - 1521
  • [23] IDENTIFICATION OF THE BCR/ABL CHIMERIC GENE IN GRANULOCYTES AND LYMPHOCYTES FROM PH-POSITIVE AND PH-NEGATIVE CML BY FLUORESCENCE IN-SITU HYBRIDIZATION (FISH)
    GARICOCHEA, B
    CHASE, A
    LAZARIDOU, A
    GOLDMAN, JM
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1153 - 1153
  • [24] EFFICACY OF NILOTINIB AFTER IMATINIB FAILURE IN PH-POSITIVE CHRONIC MYELOID LEUKEMIA: IMPACT OF ADDITIONAL CHROMOSOMAL ABERRATIONS AND FREQUENCY OF BCR-ABL POINT MUTATIONS
    Kim, T. D. K.
    Tuerkmen, S.
    Schwarz, M.
    Daniel, P.
    Doerken, B.
    Le Coutre, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 260 - 260
  • [25] A new P.K404E BCR-ABL mutation in an Ph1 positive all patient
    Torres, F.
    Ivanova, A.
    Pereira, M.
    Ferreira, F.
    Lopes, A.
    Gabriel, H.
    Tavares, P.
    Fernandes, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 520 - 521
  • [26] QUANTITATION OF MINIMAL RESIDUAL DISEASE BY COMPETITIVE PCR FOR P190 BCR-ABL MESSENGER-RNA IN PH-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    VANRHEE, F
    MARKS, DI
    FENG, L
    CROSS, NCP
    GOLDMAN, JM
    BLOOD, 1993, 82 (10) : A442 - A442
  • [27] SIGNIFICANCE OF MRD BY BCR-ABL QUANTITATIVE PCR DURINGCOMBINATION TREATMENT WITH VARIOUS TKIS PLUS CHEMOTHERAPY FOLLOWED BY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR PH-POSITIVE ADULT ALL
    Kim, D. Y.
    Lim, S. N.
    Joo, Y. D.
    Kim, S. D.
    Lee, J. H.
    Lee, J. H.
    Kim, D. H.
    Kim, K.
    Jung, C. W.
    Kim, I.
    Yoon, S. S.
    Park, S.
    Kim, B. K.
    Ahn, J. S.
    Yang, D. H.
    Lee, J. J.
    Kim, H. J.
    Kim, Y. S.
    Mun, Y. C.
    Kim, H.
    Moon, J. H.
    Sohn, S. K.
    Lee, W. S.
    Lee, S. M.
    Won, J. H.
    Hyun, M. S.
    Kim, M. K.
    Park, J.
    Lee, J. H.
    Shin, H. J.
    Eom, H. S.
    Lee, G. W.
    Ryoo, H. M.
    Bae, S. H.
    Cho, Y. U.
    Chi, H. S.
    Lee, K. H.
    HAEMATOLOGICA, 2014, 99 : 8 - 8
  • [28] Induction of imatinib resistance in clonal populations of BCR/ABL positive cells provides new insights in mechanisms of resistance development.
    Burchert, A
    Wang, Y
    Cai, D
    Hanfstein, B
    Jänike, M
    Ritter, M
    Schmidt, M
    Eilers, M
    Neubauer, A
    BLOOD, 2003, 102 (11) : 415A - 415A
  • [29] A novel I293MP mutation within BCR-ABL kinase domain in a Ph-positive acute lymphoblastic leukemia patient presenting resistant to imatinib but sensitive to nilotinib
    Kuang, Pu
    Liu, Ting
    Huang, Qi
    Ye, Yuanxin
    Xiang, Bing
    Huang, Jie
    Lei Diwu
    Wang, Yuchun
    Meng, Wentong
    Dong, Tian
    Yang, Shengyong
    Lu, Xiaojun
    LEUKEMIA RESEARCH, 2012, 36 (08) : E159 - E162
  • [30] Effect of prophylactic or pre-emptive use of tyrosine kinase inhibitors post-Allo SCT in bcr-abl positive acute lymphoblastic leukemia: a subanalysis of GITMO ph-positive ALL study
    Anna Candoni
    Davide Lazzarotto
    Alessandro Rambaldi
    Maria Vittoria Dubbini
    Paola Bresciani
    Alessandro Busca
    William Arcese
    Anna Paola Iori
    Roberto Sorasio
    Giuseppe Irrera
    Renato Fanin
    Fabio Ciceri
    Francesca Bonifazi
    Bone Marrow Transplantation, 2022, 57 : 834 - 836
1234